lobby

The Covid-19 vaccine produced by pharmaceutical firm Sanofi has finally been approved by European regulators, well after rival products from its competitors. But while the French fgroup may have been last in getting a vaccine ready to fight the pandemic, it is a different story when it comes to lobbying. As Rozenn Le Saint reports, over the last two years Sanofi has spent more than its rivals in a bid to influence the authorities in Paris and Brussels.